|Bid||67.33 x 1000|
|Ask||67.37 x 900|
|Day's range||67.24 - 69.00|
|52-week range||60.76 - 120.54|
|Beta (5Y monthly)||1.11|
|PE ratio (TTM)||21.59|
|Earnings date||02 Nov 2022 - 09 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||105.89|
One thing we could say about the analysts on Horizon Therapeutics Public Limited Company ( NASDAQ:HZNP ) - they aren't...
DUBLIN, August 03, 2022--Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance
DUBLIN, July 25, 2022--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named by Seramount (formerly Working Mother media) to its Best Companies for Multicultural Women list. The list recognizes the top 80 U.S. companies that create and use best practices in hiring, retaining and promoting multicultural women.